Evidence map›Paper›PMID 38105702›Full record

ArticleZhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences2023

Network pharmacology analysis and experimental validation of

Deyu Li, Yingchao Hu, Xin Liu, Guran Yu

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. [Bushen Yijing Formula attenuates amyloid β-protein deposi-tion and oxidative damage inZhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Deyu LiAffiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210029, China. 525956500@qq.com.
Yingchao HuAffiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210029, China.
Xin LiuAffiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210029, China.
Guran YuAffiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210029, China. dr.ygrdf@163.com.
Nanjing University of Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo explore the mechanism of

methodsThe active ingredients and targets of

resultsThrough network pharmacology, 15 potential active ingredients and 103 drug-disease targets were identified. PPI analysis showed that the

conclusions

Indexed as

Alzheimer DiseaseDrugs, Chinese HerbalFluoresceinsAmyloid beta-Protein PrecursorAmyloid Precursor Protein SecretasesAnimalsAspartic Acid EndopeptidasesCaenorhabditis elegansGlycogen Synthase Kinase 3 betaMammalsNetwork PharmacologyParalysisPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktReactive Oxygen SpeciesVascular Endothelial Growth Factor AAmyloid beta-Protein PrecursorAmyloid Precursor Protein SecretasesAspartic Acid EndopeptidasesdiacetyldichlorofluoresceinDrugs, Chinese HerbalFluoresceinsGlycogen Synthase Kinase 3 betaPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktReactive Oxygen SpeciesVascular Endothelial Growth Factor AAlzheimer’s diseaseAnemarrhenae RhizomaC. elegansLymphoblastoid cell linesOxidative stressSKNMC

Identifiers

PMID38105702
PMCPMC10945494
OpenAlexW4389735434

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.